Immune inhibitor therapy, such as drugs targeting programmed cell death (ligand) 1 [PD‐(L)1] and cytotoxic T lymphocyte antigen 4 (CTLA‐4), has achieved great success in cancer therapy. This evidence concerns the gene CD274 and cancer.